Pathogenesis of HIV-1 associated neurodegeneration

Critical Reviews in Neurobiology

Volumn 10, Issue 1, 1996, Pages 57-67

  Masliah, Eliezer ^a   Ge, Nianfeng ^b   Mucke, Lennart ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Cytokines; Excitotoxicity; gp 120; Growth factors; Interneurons; Transgenic

Indexed keywords

CYTOKINE; GLUTAMATE RECEPTOR; GLYCOPROTEIN GP 120; GROWTH FACTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL SUBPOPULATION; COGNITIVE DEFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNEURON; MOTOR DYSFUNCTION; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PYRAMIDAL NERVE CELL; REVIEW; TRANSGENIC MOUSE;

EID: 0029831084     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v10.i1.30     Document Type: Review

References (79)

1. Heaton, R. K., Velin, R. A., McCutchan, J. A., Gulevich, S. J., Atkinson, J. H., Wallace, M. R., Godfrey, H. P. D., Kirson, D. A., and Grant, I., Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment, Psychosomatic Med., 56, 8, 1994.
2. McArthur, J. C., Neurological manifestations of AIDS, Medicine, 66, 407, 1987.
3. McArthur, J. C., Becker, P. S., Parisi, J. E., Trapp, B., Selnes, O. A., Cornblath, D. R., Balakrishnan, J., Griffin, J. W., and Price, D., Neuropathological changes in early HIV-1 dementia, Ann. Neurol., 26, 681, 1989.
4. McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., Graham, N. M. H., McArthur, J. H., Selnes, O. A., Jacobson, L. P., Visscher, B. R., Concha, M., and Saah, A., Dementia in AIDS patients: incidence and risk factors, Neurology, 43, 2245, 1993.
5. Price, R. W., Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system, in HIV, AIDS, and the Brain, Price, R. W. and Perry, S. W., III., Eds., Raven Press, New York, 1994, 1.
6. Budka, H., Costanzi, G., Cristina, S., Lechi, A., Parravicini, C., Trabattoni, R., and Vago, L., Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases, Acta Neuropathol. (Berl), 75, 185, 1987.
7. Reyes, E., Mohar, A., Mallory, M., Miller, A., and Masliah, E., Patterns of brain pathology associated with human immunodeficiency virus in Mexico, Arch. Pathol. Lab. Med., 118, 1130, 1994.
8. Navia, B. A., Cho, F., Petito, C. K., and Price, R. W., The AIDS dementia complex: II. Neuropathology, Ann. Neurol, 19, 525, 1986.
9. Sharer, L. R., Epstein, L. G., Cho, E-S., Joshi, V. V., Meyenhofer, M. F., Rankin, L. F., and Petito, C. K., Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of the brain, Human Pathol, 17, 271, 1986.
10. Masliah, E., Achim, C. L., Ge, N., DeTeresa, R., Terry, R. D., and Wiley, C. A., Spectrum of human immunodeficiency virus-associated neocortical damage, Ann. Neurol, 32, 321, 1992.
11. Kure, K., Llena, J. F., Lyman, W. D., Soeiro, R., Weidenheim, K. M., Hirano, A., and Dickson, D. W., Human immunodeficiency virus-1 infection of the nervous system. An autopsy study of 268 adult, pediatric, and fetal brains, Hum. Pathol., 22, 700, 1991.
12. Petito, C. K., Cho, E-S., Lemann, W., Navia, B. .A., and Price, R. W., Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review, J. Neuropathol. Exp. Neural., 45, 635, 1986.
13. Masliah, E., Achim, C., Ge, N., and Wiley, C., Cellular neuropathology in HTV encephalitis, J. Neurol. Sci., 113, 128 (abstract), 1992.
14. Wiley, C. A., Masliah, E., Morey, M., Lemere, C., DeTeresa, R., Grafe, M., Hansen, L., and Terry, R. D., Neocortical damage during HTV infection, Ann. Neurol., 29, 651, 1991.
15. Sharer, L. R., Pathology of HTV-1 infection of the central nervous system. A review, J. Neuropathol. Exp. Neurol., 51, 3, 1992.
16. Achim, C., Wang, R., Miners, D. K., and Wiley, C. A., Brain viral burden in HIV infection, J. Neuropathol. Exp. Neurol., 53, 284, 1994.
17. Kure, K., Lyman, W. D., Weidenheim, K. M., and Dickson, D. W., Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method, Am. J. Pathol., 136, 1085, 1990.
18. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., and Oldstone, M. B., Cellular localization of human immunodeficiency virus infection within the brain of acquired immune deficiency syndrome patients, Proc. Natl. Acad. Sci. USA, 83, 7089, 1986.
19. Bell, J. E., Busuttil, A., Ironside, J. W., Rebus, S., Donaldson, Y. K., Simmonds, P., and Peutherer, J. F., Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects, J. Inf. Dis., 168, 818, 1993.
20. Merrill, J. E. and Chen, I. S. Y., HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease, FASEB J., 5, 2391, 1991.
21. Stanley, L. C., Mrak, R. E., Woody, R. C., Perrot, L. J., Zhang, S., Marshack, D. R., Nelson, S. J., and Griffin, W. S., Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease, J. Neuropathol. Exp. Neural., 53, 231, 1994.
22. Lipton, S. A., Requirement for macrophages in neuronal injury induced by HTV envelope protein gp 120, NeuroReport, 3, 913, 1992.
23. Giulian, D., Wendt, E., Vaca, K., and Noonan, C. A., The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes, Proc. Natl. Acad. Sci. USA, 90, 2769, 1993.
24. Lipton, S. A., HIV-related neurotoxicity, Brain Pathol, 1, 193, 1992.
25. Gendelman, H. E., Lipton, S. A., Tardieu, M., Bukrinsky, M. I., and Nottet, H. S. L. M., The neuropathogenesis of HTV-1 infection, J. Leukocyte Biol., 56, 389, 1994.
26. Lipton, S. A., HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists, Mol. Neurobiol., 8, 181, 1994.
27. Budka, H., Neuropathology of human immunodeficiency virus infection, Brain Pathol., 1, 163, 1991.
28. Everall, I., Luthert, P., and Lantos, P., A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia, J. Neuropathol. Exp. Neurol., 52, 561, 1993.
29. Everall, I. P., Luthert, P. J., and Lantos, P. L., Neuronal loss in the frontal cortex in HIV infection, Lancet, 337, 1119, 1991.
30. Masliah, E., Ge, N., Achim, C., Hansen, L. A., and Wiley, C. A., Selective neuronal vulnerability in HIV encephalitis, J. Neuropathol. Exp. Neurol., 51, 585, 1992.
31. Spargo, E., Everall, I. P., and Lantos, P. L., Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection, J. Neurol. Neurosurg. Psych., 56, 487, 1993.
32. Weis, S., Haug, H., and Budka, H., Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study, Acta Neuropathol., 85, 185, 1993.
33. Masliah, E., Ge, N., Morey, M., DeTeresa, R., Terry, R. D., and Wiley, C. A., Cortical dendritic pathology in human immunodeficiency virus encephalitis, Lab. Invest., 66, 285, 1992.
34. Masliah, E., Ge, N., Achim, C. L., DeTeresa, R., and Wiley, C. A., Patterns of neurodegeneration in HIV encephalitis, J. NeuroAids, 1, 161, 1996.
35. Masliah, E., Achim, C., DeTeresa, R., Ge, N., and Wiley, C. A., Cellular neuropathology in HIV encephalitis, in HIV, AIDS, and the Brain, Price, R. W. and Perry, S. W., III, Eds., Raven Press, New York, 1994, 119.
36. Perry, V. H., Lawson, L. J., and Reid, D. M., Biology of the mononuclear phagocyte system of the central nervous system and HIV infection, J. Leukocyte Biol., 56, 399, 1994.
37. Eddelston, M. P. and Mucke, L., Molecular profile of reactive astrocytes-implication for their role in neurologic disease, Neurosci., 54, 15, 1993.
38. Lipton, S. A., Models of neuronal injury in AIDS: another role for the NMDA receptor? TINS, 15, 75, 1992.
39. Dreyer, E. B., Kaiser, P. K., Offermann, J. T., and Lipton, S. A., HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists, Science, 248, 364, 1990.
40. Toggas, S. M., Masliah, E., Rockenstein, E. M., and Mucke, L., Central nervous system damage produced by expression of the HIV-1 coat protein gp 120 in transgenic mice, Nature, 367, 188, 1994.
41. Sundar, S. K., Cierpial, M. A., Kamaraju, L. S., Long, S., Hsieh, S., Lorenz, C., Aaron, M., Ritchie, J. C., and Weiss, J. M., Human immunodeficiency virus glycoprotein (gp 120) infused into rat brain induces interleukin 1 to elevate pitutiary-adrenal activity and decrease peripheral cellular immune responses, Proc. Natl. Acad. Sci. USA, 88, 11246, 1991.
42. Hill, J. M., Mervis, R. F., Avidor, R., Moody, T. W., and Brenneman, D. E., HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates, Brain Res., 603, 222, 1993.
43. Savio, T. and Levi, G., Neurotoxicity of HTV coat protein gp 120, NMDA receptors, and protein kinase C: A study with rat cerebellar granule cell cultures, J. Neurosci. Res., 34, 265, 1993.
44. Toggas, S. M., Masliah, E., and Mucke, L., Prevention of HTV-1 gp 120-induced neuronal damage in the central nervous system of transgenic mice by NMDA rèceptor antagonist memantine, Brain Res., 706, 303, 1996.
45. Lipton, S. A. and Rosenberg, P. A., Mechanisms of disease: Excitatory amino acids as a final common pathway for neurologic disorders, N. Eng. J. Med., 330, 613, 1994.
46. Kennedy, M. B., Second messengers and neuronal function, in An Introduciton to Molecular Neurobiol-ogy, Hall, Z. W., Ed., Sinauer Associates Inc., Sunderland, MO, 1992, 207.
47. 28k in cultured hippocampal neurons, Neuron, 6, 41, 1991.
48. Masliah, E., Ge, N., Achim, C. L., and Wiley, C. A., Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis, J. Neuropathol. Exp. Neurol., 54, 350, 1995.
49. Ushijima, H., Ando, S., Kunisada, T., Schroder, H.C., Klocking, H-P., Kijoa, A., and Muller, W. E. G., HTV-1 gp 120 and NMDA induce protein kinase C translocation differentially in rat primary neuronal cultures, J. AIDS, 6, 339, 1993.
50. Saitoh, T., Masliah, E., Jin, L-W., Cole, G. M., Wieloch, T., and Shapiro, P., Protein kinases and phosphorylation in neurological disorders and cell death, Lab. Invest., 64, 596, 1991.
51. Saitoh, T. and Masliah, E., Protein kinase alterations are early pathological markers of Alzheimer's disease, in Alzheimer's Disease: Advances in Cinical and Basic Research, Corain, B., Ed., John Wiley and Sons, Ltd., New York, 1993, 349.
52. De, S. K. and Marsh, J. W., HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells, J. Biol. Chem., 269, 6656, 1994.
53. Wyss-Coray, T., Masliah, E., Toggas, S. M., Lee, H. S., and Mucke, L., Dyaregulation of signal transduction pathways as potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HTV-1 encephalitis, J. Clin. Invest., 97, 789, 1996.
54. Bernardo, A., Patrizio, M., Levi, G., and Petrucci, T. C., Human immunodeficiency virus protein gp 120 interferes with β-adrenergic receptor-mediated protein phosphorylation in cultured rat cortical astrocytes, Cell Mol. Neurobiol., 14, 159, 1994.
55. Zorn, N. E., Weill, C. L., and Russell, D. H., The HTV protein, gp 120, activates nuclear protein kinase C in nuclei from lymphocytes and brain, Biochem. Biophys. Res. Commun., 166, 1133, 1990.
56. Tornatore, C., Chandra, R., Berger, J. K., and Major, E. O., HTV-1 infection of subcortical astrocytes in the pediatric central nervous system, Neurology, 44, 481, 1994.
57. Saito, Y., Sharer, L. R., Epstein, L. G., Michaels, J., Mintz, M., Louder, M., Golding, K., Cvetkovich, T. A., and Blumberg, B. M., Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues, Neurology, 44, 474, 1994.
58. Smits, A., Kato, M., Westermark, B., Nister, M., Heldin, C-H., and Funa, K., Neurotrophic activity of platelet-derived growth factor (PDGF): rat neuronal cells possess functional PDGF β-type receptors and respond to PDGF, Proc. Natl. Acad. Sci. USA, 88, 8159, 1991.
59. Masliah, E., Mallory, M., Alford, M., Hansen, L., and Saitoh, T., PDGF-BB is associated with (neuritic) neurofibrillary alterations in Alzheimer's disease, Neurobiol. Aging, 16, 549, 1995.
60. Kolson, D. L., Collman, R., Hrin, R., Balliet, J. W., Laughlin, M., McGann, K. A., Debouck, C., and Gonzalez-Scarano, F., Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation, J. Gen. Virol., 75, 1927, 1994.
61. Cupp, C., Taylor, J. P., Khalili, K., and Amini, S., Evidence for stimulation of the transforming growth factor beta 1 promoter by HTV-1 Tat in cells derived from CNS, Oncogene, 8, 2231, 1993.
62. Wahl, S. M., Allen, J. B., McCartney-Francis, N., Morganti-Kossmann, M. C., Kossmann, T., Ellingsworth, L., Mai, U. E. H., Mergenhagen, S. E., and Orenstein, J. M., Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome, J. Exp. Med., 173, 981, 1991.
63. Ensoli, F., Ensoli, B., and Thiele, C. J., HTV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor, Virology, 200, 668, 1994.
64. Mucke, L., Abraham, C. R., Ruppe, M. D., Rockenstein, E. M., Toggas, S. M., Alford, M., and Masliah, E., Protection against HTV-1 gp 120-induced brain damage by neuronal overexpression of human amyloid precursor protein (hAPP), J. Exp. Med., 181, 1551, 1995.
65. Eitan, S., Zisling, R., Cohen, A., Belkin, M., Hirschberg, D. L., Lotan, M., and Schwartz, M., Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration, Proc. Natl. Acad. Sci. USA, 89, 5442, 1992.
66. Campbell, I., Abraham, C. R., Masliah, E., Kemper, Ph., Inglis, J. D., Oldstone, M. B. A., and Mucke, L., Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6, Proc. Natl. Acad. Sci. USA, 90, 10061, 1993.
67. Cvetkowich, T. A., Lazar, E., Blumberg, B. M., Saito, Y., Eskin, T. A., Reichman, R., Baram, D. A., del Cerro, C., Gendelman, H. E., del Cerro, M., and Epstein, L. G., Human immunodeficiency virus type 1 infection of neural xenografts, Proc. Natl. Acad. Sci. USA, 89, 5162, 1992.
68. Giulian, D., Vaca, K., and Corpuz, M., Brain glia release factors with opposing actions upon neuronal survival, J. Neurosci., 13, 29, 1993.
69. Giulian, D., Li, J., Leara, B., and Keenen, C., Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture, Neurochem. Int., 25, 227, 1994.
70. Achim, C. L., Masliah, E., Ge, N., Heyes, M. P., Wang, R., Miners, D., and Wiley, C. A., Immune activation and neurologic damage in HIV encephalitis, J. Neuropathol. Exp. Neurol, 52, 315 (abstract), 1993.
71. Achim, C. L., Morey, M. K., and Wiley, C. A., Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients, AIDS, 5, 535, 1991.
72. Sippy, B. D., Hofman, F. M., and Hinton, D. R., Cytokine expression in the brains of patients with AIDS, J. Neuropathol. Exp. Neurol., 52, 314 (abstract), 1993.
73. Tyor, W. R., Glass, J. D., Griffin, J. W., Becker, P. S., McArthur, J. C., Bezman, L., and Griffin, D. E., Cytokine expression in the brain during the acquired immunodeficiency syndrome, Ann. Neural., 31, 349, 1992.
74. Benveniste, E. N., Cytokine circuits in brain. Implications for AIDS dementia complex, Assoc. Res. Nerv. Mental Dis., 72, 71, 1994.
75. Gelbard, H. A., Nottet, H. S. L. M., Swindells, S., Jett, M., Dzenko, KA., Genis, P., White, R., Wang, L., Choi, Y-B., Zhang, D., Lipton, S. A., Tourtellotte, W. W., Epstein, L. G., and Gendelman, H. E., Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin, J. Virol., 68, 4628, 1994.
76. Heyes, M. P., Saito, K., Crowley, J. S., Davis, L. E., Demitrack, M. A., Der, M., Billing, L. A., Elia, J., Kruesi, M. J., and Lackner, A., Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease, Brain, 115, 1249, 1992.
77. Masliah, E., Ge, N., Achim, C. L., and Wiley, C. A., Cytokine receptor localization in human central nervous system in vivo and in vitro: correlation with HIV infection, Brain Res., 663, 1, 1994.
78. Mucke, L., Masliah, E., and Campbell, I. L., Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines, Curr. Topics Microbiol. Immunol., 202, 187, 1995.
79. Masliah, E., Mallory, M., Ge, N., Godson, C., and Saitoh, T., Phorbol ester-induced neuritic alterations in the rat neocortex. Structural and immunocytochemical studies, Mol. Chem. Neuropathol., 20, 125, 1993.